The present invention provides biomarkers for schizophrenic and bipolar disorders and methods of diagnosis, monitoring and screening associated with the biomarkers and kits for performing such methods.
VGF PEPTIDE FRAGMENTS AS BIOMARKERS FOR SCHIZOPHRENIC AND BIPOLAR DISORDERS